Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vs Conventional Glycemic Control in Diabetic Foot Ulcer Healing
NCT03740581Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in diabetic foot ulcer (DFU) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Number of participants with complete wound closure (epithelialisation) at 12 weeks. Status: unknown.
02
Drugs
human insulin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03740581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740581.